Cryoport Reports Third Quarter 2024 Financial Results [Yahoo! Finance]
CryoPort, Inc. (CYRX)
NASDAQ:AMEX Investor Relations:
ir.cryoport.com
Company Research
Source: Yahoo! Finance
Supported a record total of 691 global clinical trials as of September 30, 2024 Company reaffirmed full year 2024 revenue guidance of to $235 million NASHVILLE, Tenn. Nov. 7, 2024 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) (Cryoport), a global leader in supply chain solutions for the life sciences industry, today announced financial results for its third quarter (Q3) and first nine months ( 9M ) of 2024. Jerrell Shelton , CEO of Cryoport, remarked, "Our Life Sciences Services business showed 9% growth during the third quarter, with BioStorage/BioServices revenue increasing by 12% compared to the third quarter of last year. The increase in our services revenue was coupled with a substantial improvement in gross margin to 46% for our services business. "Reflecting on our performance through the third quarter, we are maintaining our full-year revenue forecast of $225 million to $235 million , anticipating continued growth in our services business while acknowledging the ongoi
Show less
Read more
Impact Snapshot
Event Time:
CYRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CYRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CYRX alerts
High impacting CryoPort, Inc. news events
Weekly update
A roundup of the hottest topics
CYRX
News
- Cryoport, Inc. (NASDAQ: CYRX) is now covered by analysts at Guggenheim. They set a "buy" rating and a $11.00 price target on the stock.MarketBeat
- Cryoport Expands IntegriCellâ„¢ Cryopreservation Services Solution with Opening of New Center of Excellence in EuropePR Newswire
- CryoPort Inc (CYRX) Q3 2024 Earnings Call Highlights: Strong Service Growth Amid Market Challenges [Yahoo! Finance]Yahoo! Finance
- Cryoport, Inc. (NASDAQ: CYRX) had its price target lowered by analysts at Roth Mkm from $18.00 to $15.00. They now have a "buy" rating on the stock.MarketBeat
- Cryoport Reports Third Quarter 2024 Financial ResultsPR Newswire
CYRX
Earnings
- 11/7/24 - Beat
CYRX
Sec Filings
- 12/13/24 - Form 4
- 12/4/24 - Form 4
- 12/2/24 - Form 4
- CYRX's page on the SEC website